PMCPA Case
| Case | AUTH/2811/12/15 |
| Complainant | Anonymous, non-contactable (described self as a UK health professional) |
| Company | Daiichi-Sankyo |
| Issue | Exhibition stand design and hospitality; photo booth emailing delegate photos; allegations of extravagance/party atmosphere |
| Event | European Society of Cardiology (ESC) Congress, London, 29 Aug – 2 Sep 2015 |
| Medicine referenced | Lixiana (edoxaban) |
| Applicable Code year | 2015 |
| Complaint received | 21 December 2015 |
| Case completed | 13 May 2016 |
| Panel decision | Breach Clause 18.1 and Clause 9.1; No breach Clause 9.7 |
| Appeal outcome | Breach Clause 18.1 upheld; Clause 9.1 breach overturned (no breach); No breach Clause 9.7 maintained |
| Sanctions | Undertaking received; Additional sanctions: Not stated |
Download the full case report (PDF)
Reviewed by Dr Anzal Qurbain (FFPM) — ABPI Final Signatory
Got a question about this case?
Ask one of our 13 specialist ABPI advisors — instant answers, 24/7.
⭐ Business Intelligence Access
See the full compliance picture for every pharma company
291 Company Intelligence Reports — breach patterns, appeal history, industry ranking, PDF export.
One real case. One key lesson. Every week — free.